VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 136 filers reported holding VBI VACCINES INC in Q2 2021. The put-call ratio across all filers is 2.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $29,831 | -36.7% | 98,453 | -18.3% | 0.00% | – |
| Q4 2022 | $47,103 | -46.5% | 120,437 | -3.7% | 0.00% | – |
| Q3 2022 | $88,000 | -37.6% | 125,124 | -28.4% | 0.00% | – |
| Q2 2022 | $141,000 | -68.2% | 174,791 | -34.6% | 0.00% | -100.0% |
| Q1 2022 | $443,000 | -23.0% | 267,148 | +8.8% | 0.00% | 0.0% |
| Q4 2021 | $575,000 | -16.9% | 245,561 | +10.4% | 0.00% | 0.0% |
| Q3 2021 | $692,000 | +52.4% | 222,474 | +64.2% | 0.00% | 0.0% |
| Q2 2021 | $454,000 | +14.9% | 135,494 | +6.6% | 0.00% | 0.0% |
| Q1 2021 | $395,000 | +100.5% | 127,155 | +77.6% | 0.00% | – |
| Q4 2020 | $197,000 | -47.6% | 71,596 | -45.5% | 0.00% | -100.0% |
| Q3 2020 | $376,000 | +916.2% | 131,481 | +996.2% | 0.00% | – |
| Q2 2020 | $37,000 | -28.8% | 11,994 | -78.2% | 0.00% | – |
| Q1 2020 | $52,000 | -31.6% | 55,000 | 0.0% | 0.00% | – |
| Q4 2019 | $76,000 | – | 55,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 52,335,002 | $37,157,000 | 1.08% |
| GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $1,325,000 | 0.14% |
| Newbridge Financial Services Group, Inc. | 177,409 | $125,000 | 0.07% |
| Wealth Alliance Advisory Group, LLC | 193,000 | $136,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 624,438 | $441,000 | 0.06% |
| ArchPoint Investors | 65,000 | $46,000 | 0.02% |
| Cambridge Investment Research Advisors, Inc. | 3,132,545 | $2,211,000 | 0.01% |
| GRIMES & COMPANY, INC. | 288,901 | $204,000 | 0.01% |
| CARDIFF PARK ADVISORS, LLC | 64,100 | $45,000 | 0.01% |
| WEALTHSOURCE PARTNERS, LLC | 102,100 | $72,000 | 0.01% |